[New European approvals: Durvalumab - In first line metastatic small-cell lung cancer]

MeSH terms

• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized / therapeutic use
• Antineoplastic Agents / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Carboplatin / therapeutic use
• Clinical Trials, Phase III as Topic
• Drug Approval*
• Humans
• Immunotherapy
• Lung Neoplasms / drug therapy*
• Nivolumab / therapeutic use
• Small Cell Lung Carcinoma / drug therapy*
• Topotecan / therapeutic use